Jb. Schachter et al., 2ND MESSENGER CASCADE SPECIFICITY AND PHARMACOLOGICAL SELECTIVITY OF THE HUMAN P-2Y1-PURINOCEPTOR, British Journal of Pharmacology, 118(1), 1996, pp. 167-173
1 The coding sequence of the P-2Y1-purinoceptor was cloned from a huma
n genomic library. 2 The open reading frame encodes a protein of 373 a
mino acids that is 83% identical to the previously cloned chick and tu
rkey P-2Y1-purinoceptor and is greater than or equal to 95% homologous
to the recently cloned rat, mouse, and bovine P-2Y1-purinoceptors 3 T
he human P-2Y1-purinoceptor was stably expressed in 1321N1 human astro
cytoma cells using a retroviral vector. Although the P-2Y1-purinocepto
r agonist, 2MeSATP, had no effect on inositol phosphate accumulation i
n 1321N1 cells infected with the control virus, this agonist markedly
stimulated inositol phosphate accumulation in cells infected with the
P-2Y1-purinoceptor virus. No effect of 2MeSATP on cyclic AMP accumulat
ion was observed in P-2Y1-receptor-expressing 1321N1 cells. 4 The phar
macological selectivity of 18 purinoceptor agonists was established fo
r the expressed human P-2Y1-purinoceptor, 2MeSATP was more potent than
ATP but less potent than 2MeSADP. ADP also was more potent than ATP.
A similar maximal effect was observed with most agonists tested. Howev
er, alpha,beta-MeATP had no effect and 3'-NH2-3'-deoxyATP and A(2)P(4)
were partial agonists. The order of potency of agonists for activatio
n of the turkey P-2Y1-purinoceptor, also stably expressed in 1321N1 ce
lls, was identical to that observed for the human P-2Y1-purinoceptor.
5 C6 glioma cells express a P-2Y-purinoceptor that inhibits adenylyl c
yclase but does not activate phospholipase C. Expression of the human
P-2Y1-purinoceptor in C6 cells conferred 2MeSATP-stimulated inositol l
ipid hydrolysis to these cells. The phospholipase C-activating human P
-2Y1-purinoceptor could be delineated from the endogenous P-2Y-purinoc
eptor of C6 glioma cells by use of the P-2-purinoceptor antagonist, PP
ADS, which blocks the P-2Y1-purinoceptor but does not block the endoge
nous P-2Y- purinoceptor of C6 cells. P-2-purinoceptor agonists also ex
hibited differential selectivities for activation of these two P-2Y-pu
rinoceptors.